Trial Profile
Study of alternate formulation of aripiprazole in agitated patients with schizophrenic disorders
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 27 Mar 2007
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Haloperidol
- Indications Agitation; Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 01 Feb 2007 Results have been presented.
- 16 Nov 2006 Status change
- 09 Oct 2005 New trial record.